SCHEMBL24601431

SCHEMBL24601431

CCOC(=O)C[C@H](C)c1cc2cc(N)ccc2s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.46
MAPT P10636 6/20 0.46
HPGD P15428 4/20 0.46
SHMT2 P34897 1/20 0.46
KDM4E B2RXH2 3/20 0.42
HTT P42858 1/20 0.42
F9 P00740 1/20 0.38
F10 P00742 1/20 0.38
LMNA P02545 4/20 0.37
CYP1A2 P05177 4/20 0.37
NPC1 O15118 4/20 0.37
RAB9A P51151 4/20 0.37
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
GAA P10253 3/20 0.37
HSD17B10 Q99714 3/20 0.37
CYP3A4 P08684 2/20 0.37
ALOX15 P16050 2/20 0.37
MAOA P21397 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24601427 0.76 MAPT (0.53) ALDH1A1MAPTHPGDKDM4EHTT
SCHEMBL1000816 0.74 PTPN2 (0.49) ALDH1A1MAPTHPGDSHMT2KDM4E
SCHEMBL5691331 0.73 ALDH1A1 (0.62) ALDH1A1MAPTKDM4EHTTF10
SCHEMBL5670458 0.73 ALDH1A1 (0.62) ALDH1A1MAPTKDM4EHTTF10
Hydrochloric Acid SCHEMBL6983330 0.73 PTPN2 (0.48) ALDH1A1MAPTHPGDSHMT2KDM4E
SCHEMBL23612300 0.72 ALDH1A1 (0.39) ALDH1A1MAPTKDM4ELMNACYP1A2
SCHEMBL24518550 0.72 ALDH1A1 (0.45) ALDH1A1MAPTHPGDSHMT2KDM4E
SCHEMBL21199815 0.71 ALDH1A1 (0.47) ALDH1A1MAPTKDM4EHTTF10
SCHEMBL12660760 0.69 CHRNA7 (0.48) HPGDLMNACYP1A2RAB9AKMT2A
SCHEMBL27582427 0.69 ALDH1A1 (0.42) ALDH1A1MAPTHPGDSHMT2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220213052-A1 INHIBITORS OF RNA-BINDING PROTEINS, COMPOSITIONS THEREOF, AND THERAPEUTIC USES THEROF THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2022-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213052-A1 INHIBITORS OF RNA-BINDING PROTEINS, COMPOSITIONS THEREOF, AND THERAPEUTIC USES THEROF HNRNPF, RBM3, RBM15 ALDH1A1 3972/4885MAPT 1903/4885HPGD 4430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.